期刊文献+

基质金属蛋白酶9及其组织型抑制因子1在高血压大鼠血液及组织中的变化 被引量:5

Changes of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in serum and tissues in hypertensive rats
下载PDF
导出
摘要 目的探讨肾血管性高血压大鼠(RHR)血清、脑及血管组织中基质金属蛋白酶9(MMP-9)和组织型基质金属蛋白酶抑制因子1(TIMP-1)的表达以及血压与两者的关系。方法雄性SD大鼠80只随机分成RHR组(40只)和假手术组(40只)。RHR组采用双肾-双夹法制作高血压大鼠模型,鼠尾测压仪测定血压。根据Longa5评分法和病理学结果确定脑卒中;Western blot和免疫组化测定脑组织和血管中MMP-9和TIMP-1的表达,双抗体夹心ELISA检测血清MMP-9和TIMP-1水平。结果与假手术组比较,RHR组大鼠术后2、4、6、8、10、12周血压均明显升高[(157±9.0)比(128±7.0),(176±10.0)比(122±6.0),(194±8.0)比(117±6.5),(202±12.0)比(124±8.0),(218±15.0)比(126.±8.5),(224±20.0)比(129.±9.0)mm Hg,均P<0.05];术后12周,RHR大鼠血清MMP-9高于假手术组[(783.4±109.79)比(573.4±109.59)ng/m L,P<0.05];而RHR大鼠血清TIMP-1低于假手术组[(313.02±83.9)比(976.19±191.1)pg/m L,P<0.05]。同时,RHR大鼠脑组织和血管MMP-9的表达均明显高于假手术组(均P<0.05),而TIMP-1的表达则均明显低于假手术组(均P<0.05)。Pearson相关分析显示收缩压与血清、脑及血管组织中的MMP-9水平均呈正相关(r=0.557,r=0.774和r=0.661,均P<0.05),而与TIMP-1水平均呈负相关(r=-0.481,r=-0.535和r=-0.685,均P<0.01)。结论肾血管性高血压大鼠血清、脑和血管组织中MMP-9表达升高,而TIMP-1表达降低。两者在血液和组织中的变化趋势保持一致,血压的升高与血液和组织中MMP-9的升高和TIMP-1的降低相关。 Objective To investigate the expressions of metalloproteinase-9 (MMP-9) in serum, brain and aorta matrix and tissue inhibitor of metalloproteinase-1 ( TIMP-1 ) in renovascular hypertensive rats ( RHR), and to evaluate the association between blood pressure and levels of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloprotein- ase-1 (TIMP-1). Methods Eighty healthy male SD rats were randomly divided into RHR group ( n = 40) and sham-opera- ted group (n =40). Hypertension was induced by two-kidney, two-clip (2K-2C)clamps. Systolic blood pressure (SBP) was measured every 2 weeks during 12 weeks using a tail pressure meter. Stroke was confirmed by Longa' s five-point scale and pathological examination. The expressions of MMP- 9 and TIMP-1 in the brain and aorta tissues were detected by Western blot and immunohistochemistry. The levels of serum MMP-9 and TIMP-1 were measured by double-antibody sandwich enzyme-linked immunosorbent assay ( DAS-ELISA). Results Compared with the sham-operated group, SBP stayed signif- icantly elevated in the RHR group at 2, 4, 6, 8, 10 and 12weeks after the operation [ (157 ±9.0) vs. (128 ±7.0), (176±10.0) vs. (122±6.0), (194 ±8.0)vs. (117 ±6.5), (202 ± 12.0)vs. (124 ±8.0), (218 ±15.0) vs. (126 ±8.5),and (224±20.0)vs. (129±9.0) mm Hg, allP〈 0.05]. 12 weeks after the surgery, the level of ser- um MMP-9 in the RHR group was kept significantly higher than that in the sham-operated group [ (783.4 ± 109. 79)vs. (573.4 ± 109.59) ng/mL, P 〈 0.05 ], and the serum TIMP-1 level was lower in the RHR group than that in the sham-op- erated group[ (313.02 ±83.9) vs. (976. 19 ± 191.1) pg/mL, P 〈0. 05]. MMP-9 expressions were significantly higher in the brain and aorta in the RHR group than that in the sham-operated group ( both P 〈 0.05 ) , and TIMP-1 expressions were lower than that in the sham-operated group( both P 〈 0.05). The Pearson correlation analysis showed that MMP-9 lev- els in serum,brain and aorta were positively correlated with systolic blood pressure ( r = 0. 557,r = 0. 774 and r = 0. 661 ,all P 〈0.05) , and TIMP-1 levels were negatively correlated with systolic blood pressure(r = -0. 481 ,r = -0. 535 and r = - 0. 685 ,all P 〈0.01). Conclusions Hypertension induces increased MMP-9 and decreased TIMP-I in serum, brain and aorta in renovascular hypertensive rats. There are consistent alterations of circulating and tissue MMP-9 and TIMP-1 levels in renovascular hypertensive rats. There is a relationship between increased blood pressure and high MMP-9 and low TIMP- 1 in serum and tissues.
出处 《中国实验动物学报》 CAS CSCD 北大核心 2017年第2期138-145,共8页 Acta Laboratorium Animalis Scientia Sinica
基金 国家自然科学基金项目(编号:81500985) 南方医科大学科研启动项目(编号:PY2014N080)
关键词 肾血管性高血压大鼠 基质金属蛋白酶9 组织型基质金属蛋白酶抑制因子1 Renovascular hypertensive rats Stroke Matrix metalloproteinase-9 Tissue inhibitor of metalloprotei-Base-1
  • 相关文献

参考文献1

二级参考文献14

  • 1吴爱明,张冬梅,王硕仁,孙逸坤,牛福玲,吕晞滢,索红亮.高血压合并脑梗死患者血清基质金属蛋白酶-9水平的变化及其危险因素分析[J].临床神经病学杂志,2008,21(6):444-445. 被引量:5
  • 2张毅,蔡琰,苗玲.基质金属蛋白酶-9与缺血性脑损伤和脑梗死后出血的关系[J].临床神经病学杂志,2005,18(5):397-398. 被引量:11
  • 3张莉娜,陈健尔,张涛,崔军.高血压流行特征与相关因素调查[J].中国公共卫生,2006,22(1):93-94. 被引量:95
  • 4Jackson ZS, Gotlieb AI, Langille BL. Wall tissue remodeling regulates longitudenal tension in arteries[J]. Circ Res, 2002,90(8): 918-925.
  • 5Zeng JH, Zhang YQ, Mo JW, etal. Two-kidney, two cliprenovascular hypertensive rats can be used as stroke-prone rats[J].Stroke,1998,29(8):1708-1714.
  • 6Newby AC. Dual role of matrix metallop roteinases(Matrixins)in intimal thickening and atherosclerotic plaque rupture[J]. Physiol Rev, 2005,85(1) 1-31.
  • 7Tayehjee MH, Nadar S, Blann AD, etal. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the anglo-scandinavian cardiac outcomes trial (ASCOT) [J]. Am J Hypertens,2004,17(9) :764-769.
  • 8Bendeck MP. Matrix metalloproteinases: are they antiatherogenic hut proaneurysmal[J]. Circ Res,2002,90(8) :836-838.
  • 9Castellanos M, Sobrino T, Millan M, et al. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenehymal hematoma after thrombolytie therapy in acuteischemic stroke:a multicenter confirmatory study [J]. Stroke,2007,38(6) : 1855-1859.
  • 10Mceniery CM, Wallace S, Dakham Z, et al. Matrix metalloproteinase 9(MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness[J]. Arterioscler Thromb Vasc Biol,2005,25(2)372-378.

共引文献1

同被引文献60

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部